Literature DB >> 19029855

Papillary thyroid cancer: controversies in the management of neck metastasis.

H Carter Davidson1, Brian J Park, Jonas T Johnson.   

Abstract

OBJECTIVE/HYPOTHESIS: To describe our institution's experience with the management of cervical metastasis in papillary thyroid carcinoma (PTC) and suggest a treatment strategy based on the incidence of pathologic nodes and cervical recurrence in patients undergoing varied surgical approaches to address lymphadenopathy over the study dates.
MATERIALS AND METHODS: Between December 1, 1972 and September 1, 2007, 183 total patients diagnosed with PTC at the University of Pittsburgh Medical Center were treated with lymphadenectomy. Pathologic parameters, including number of pathologic nodes and extent of lymphadenectomy were correlated to disease recurrence. STUDY
DESIGN: Retrospective chart review.
RESULTS: The incidence of pathologic nodes in lymphadenectomy specimens (57.9%) and the recurrence rate (33.7%) were high, in our study population. In comparing techniques with address lymphadenopathy, the highest recurrence rate was observed in patients with pathologic nodes treated with "lymph node plucking" procedures at the time of thyroidectomy and those patients with multiple nodes involved. Few patients with no pathologic nodes, regardless of lymphadenectomy extent recurred.
CONCLUSIONS: Our data show that limited neck dissection and disease burden are associated with the highest rates of cervical recurrence in regional metastatic PTC. Comprehensive functional neck dissection would seem to offer the patient the best opportunity for control of cervical metastasis. The American Thyroid Association recommends thyroglobulin monitoring and ultrasound evaluation of the neck in all postoperative patients. Therefore patients with the diagnosis of papillary thyroid cancer need preoperative ultrasound of the lateral neck and fine needle aspiration of suspicious nodes to avoid under-treating patients scheduled for total thyroidectomy. Neck dissection of the compartments in which pathologic nodes were detected (central, lateral, or both) should then be undertaken at the time of initial thyroidectomy. Eliminating all disease remains elusive and the prognostic significance of cervical disease persistence and recurrence is still unknown. Patients with cervical metastasis are at substantial risk of regional recurrence, necessitating repeat surgery. Parathyroid implantation should be considered at the time of the initial surgery to reduce the risk of hypoparathyroidism should subsequent procedures be required. More information will be necessary to better understand the prognostic significance of these regional metastases. In the interim, many patients may be over-treated, whereas some remain at risk of death because of disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19029855     DOI: 10.1097/MLG.0b013e31818550f6

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  23 in total

1.  A novel definition of extrathyroidal invasion for patients with papillary thyroid carcinoma for predicting prognosis.

Authors:  Muneki Hotomi; Iwao Sugitani; Kazuhisa Toda; Kazuyoshi Kawabata; Yoshihide Fujimoto
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

Review 2.  Prophylactic central neck disection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Juan J Sancho; Thomas W Jay Lennard; Ivan Paunovic; Frédéric Triponez; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2013-12-19       Impact factor: 3.445

Review 3.  Individualized optimal surgical extent of the lateral neck in papillary thyroid cancer with lateral cervical metastasis.

Authors:  Jae-Yong Park; Bon Seok Koo
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-16       Impact factor: 2.503

4.  Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons.

Authors:  Hiroshi Takami; Yasuhiro Ito; Takahiro Okamoto; Akira Yoshida
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

5.  Level IIb lymph node metastasis in thyroid papillary carcinoma.

Authors:  Yusuf Vayisoglu; Cengiz Ozcan; Ozgur Turkmenoglu; Kemal Gorur; Murat Unal; Ahmet Dag; Koray Ocal
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01-07       Impact factor: 2.503

6.  Value of ultrasound in detecting central compartment lymph node metastases in differentiated thyroid carcinoma.

Authors:  Aviram Mizrachi; Raphael Feinmesser; Gideon Bachar; Ohad Hilly; Maya Cohen
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-24       Impact factor: 2.503

7.  Clinical and imaging assessment of cervical lymph node metastasis in papillary thyroid carcinomas.

Authors:  Yoon Jung Choi; Ji Sup Yun; Shin Ho Kook; Eun Choel Jung; Yong Lai Park
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

8.  Clinical implication of the number of central lymph node metastasis in papillary thyroid carcinoma: preliminary report.

Authors:  Yoon Se Lee; Yun Sung Lim; Jin-Choon Lee; Soo-Geun Wang; In-Ju Kim; Byung-Joo Lee
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

9.  Thyroidectomy and lymph node dissection in papillary thyroid carcinoma.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  J Thyroid Res       Date:  2010-11-10

Review 10.  Involvement of level IIb lymph node metastasis and dissection in thyroid cancer.

Authors:  Yusuf Vayisoglu; Cengiz Ozcan
Journal:  Gland Surg       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.